Jun-Tao Lin, Chao Zhang, Lixu Yan, Xuening Yang, Song Dong, Ben-Yuan Jiang, Qiang Nie, Ri-qiang Liao, Jing Kang, Zi-Yi Xu, Jia-Tao Zhang, Jie Yang, Sheng Zhang, Jing-Yu Hou, Rui Fu, Zi-Hao Chen, Zhen-Bin Qiu, Yi-Long Wu, Wenzhao Zhong. "Neoadjuvant almonertinib followed by chemo-immunotherapy in II-IIIb EGFR-mutant NSCLC: A single arm, phase II study (NEOVADE).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8509